Chronic hand eczema commonly reflects overlapping irritant, allergic, atopic, and protein-driven mechanisms, making patch ...

Tampa General Hospital and Moffitt Cancer Center are both racing to expand outpatient capacity, from added observation bays ...

Employers can improve access to cancer care and address rising costs by pairing existing benefits with targeted strategies, ...

Debra Patt, MD, PhD, MBA, MPH, discusses how AI can streamline prior authorization and revenue cycle workflows in community ...

Advanced primary care may be one of employers' strongest tools for catching cancer earlier, and better support during and ...

Regulatory volatility since 2020, including IRA price negotiation, MFN pricing directives, and Medicaid best-price dynamics, ...

The rapid expansion of cell and gene therapies and other very high-cost drugs may give value-based contracting a second life, ...

Yesterday, September 24, the FDA approved the combination of belzutifan (WELIREG; Merck) plus lenvatinib (LENVIMA; Eisai) to ...

Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...

FDA movement of peptides toward 503A bulks listing advanced despite internal scientific objections citing absent human ...

SHAP ranked age, BMI, and vaginal delivery count as dominant contributors, followed by systolic blood pressure, HbA1c, PIR, ...

Seshadri, MD, speaks on CLL's shift toward fixed-duration, MRD-guided regimens, MRD testing barriers, and open questions on ...